documents: FDA-2017-D-6580-5125

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-D-6580-5125 FDA FDA-2017-D-6580 Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Extension of Comment Period Notice Extension of Comment Period 2020-01-08T05:00:00Z 2020 1 2020-01-08T05:00:00Z   2020-01-08T14:54:20Z 2020-00091 0 0 090000648427bef7

Links from other tables